-
Report details
-
49
Figures
-
90
Tables
-
Chapter One: Executive Summary
-
IVD Procedure Volume Estimate and Forecast
-
Scope & Methodology
-
About Kalorama Information
-
Chapter Two: Introduction
-
Overview
-
Industry Trends
-
Demographic Trends
-
Global Population and Aging
-
Workforce Reduction
-
Increase in Chronic Diseases
-
Personalized Medicine
-
New Infectious Disease Threats
-
Tickborne Diseases (TBDs)
-
Zika
-
Chagas
-
Dengue
-
Ebola
-
Chikungunya
-
Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)
-
Marburg
-
SARS-CoV-2 (COVID-19)
-
Monkeypox
-
Emerging and Emerged Markets
-
Chapter Three: IVD Testing Segments
-
IVD Testing Trends
-
Segment Growth Projections
-
POC Testing
-
Clinical Chemistry
-
Immunoassays
-
Mass Spectrometry (Immuno)
-
Molecular Assays
-
Hematology
-
Coagulation
-
Conventional Microbiology
-
Blood Grouping/Typing
-
Histology/Cytology
-
Segment Product Sales
-
Chapter Four: Global IVD Markets
-
General
-
North America
-
Mexico, Central & South America
-
Brazil
-
Mexico
-
Other Central & South America
-
Western Europe
-
France
-
Germany
-
Italy
-
Spain
-
United Kingdom
-
Other Western Europe
-
Eastern Europe
-
Russia
-
Other Eastern Europe
-
Asia/Pacific
-
China
-
Japan
-
Other Asian Countries and Territories
-
Middle East
-
Africa
-
Chapter Five: Point-of-Care (POC) Procedures
-
Global POC Procedure Volume by Test Type
-
POC Self Tests
-
Traditional Blood Glucose Monitoring Activities
-
Continuous Blood Glucose Monitoring
-
Pregnancy and Fertility Testing
-
Coagulation Testing
-
Fecal Occult Blood Testing
-
Drugs of Abuse Testing
-
H. Pylori Testing
-
HIV Testing
-
Infectious Disease
-
Cholesterol Testing
-
POC Urinalysis Testing
-
Other POC Self-Testing
-
POC Self-Testing Product Sales
-
Pricing Trends
-
POC Professional Testing
-
POC Professional Blood Glucose Testing Procedures
-
POC Professional Critical Care Testing
-
POC Fertility Testing
-
POC Professional Infectious Disease Testing
-
POC Professional Cardiac Marker Testing
-
POC Professional Cholesterol/Lipid Testing
-
POC Professional Coagulation Testing
-
POC Professional HbA1C Testing
-
POC Professional Hematology Testing
-
POC Professional Fecal Occult Blood Screening
-
POC Professional Drugs of Abuse Testing
-
POC Professional Urinalysis Testing
-
Other POC Professional Testing
-
POC IVD Product Sales
-
Pricing Trends
-
Chapter Six: Clinical Chemistry Procedures
-
Types of Tests
-
General Chemistry
-
Blood Gases & Electrolytes
-
Urinalysis
-
Global Sales of Clinical Chemistry Products
-
Pricing Trends
-
Chapter Seven: Immunoassay Procedures
-
Technologies
-
Labeling Techniques
-
Enzyme Immunoassays
-
Fluorescence Polarization Immunoassays (FPIAs)
-
Radioimmunoassays (RIAs)
-
Testing Procedures & Product Sales
-
Cardiac Markers
-
Tumor Markers
-
Autoimmune Conditions
-
Allergy Conditions
-
Thyroid Conditions
-
Proteins
-
Anemia
-
Fertility Testing
-
Therapeutic Drug Monitoring
-
Vitamin D
-
Diabetes/HbA1c
-
Drugs of Abuse
-
Infectious Diseases
-
Instruments
-
Pricing Trends
-
Chapter Eight: Molecular Testing Procedures
-
Types of Tests
-
Testing Technologies
-
Infectious Diseases
-
Blood Screening
-
Cancer
-
Transplant Matching
-
Thrombophilia SNPs
-
Inherited Diseases
-
Other Molecular Tests
-
Prenatal
-
Global Sales of Molecular IVD Products
-
Pricing Trends
-
Chapter Nine: Laboratory-Based Hematology Procedures
-
Types of Tests
-
Global Sales of Hematology Products
-
Pricing Trends
-
Chapter Ten: Coagulation Testing Procedures
-
Types of Tests
-
Global Sales of Coagulation Products
-
Pricing Trends
-
Chapter Eleven: Microbiology Procedures
-
Types of Tests
-
ID/AST Automated Panels & Reagents
-
Manual Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Global Sales of Conventional IVD Microbiology Products
-
ID/AST Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Pricing Trends
-
Chapter Twelve: Blood Grouping/Typing Procedures
-
Types of Tests
-
Blood Grouping/Typing Product Sales
-
Pricing Trends
-
Chapter Thirteen: Histology/Cytology Procedures
-
Types of Tests
-
Immunohistochemistry Tests
-
In Situ Hybridization Tests
-
Pap Tests
-
Traditional Non-Pap Stains
-
Circulating Tumor Cells
-
Flow Cytometry
-
Histology/Cytology IVD Product Sales
-
Pricing Trends
-
Chapter Fourteen: Company Profiles
-
Abbott Diagnostics
-
Recent Revenue History
-
Core Lab
-
Hematology
-
Blood Banking
-
Infectious Diseases - Molecular
-
Diabetes
-
HIV Point of Care
-
i-STAT Business
-
COVID-19
-
Agilent Technologies
-
Recent Revenue History
-
Agilent in Genomics
-
Cytogenetic Analysis
-
Sequencing
-
Flow Cytometry
-
Companion Diagnostics - Dako
-
COVID-19
-
Becton, Dickinson and Company (BD)
-
Recent Revenue History
-
Cytology
-
Molecular Microbiology
-
Traditional Microbiology - ID/AST
-
Blood Culture
-
Hospital Acquired Infections
-
Blood Collection
-
Mass Spectrometry
-
COVID-19
-
bioMérieux Inc.
-
Recent Revenue History
-
Traditional Microbiology
-
Blood Culture
-
Immunoassays
-
Mass Spectrometry
-
BioFire Diagnostics Business
-
COVID-19
-
Bio-Rad Laboratories, Inc.
-
Recent Revenue History
-
Blood Bank
-
Immunoassays
-
COVID-19
-
Bruker Corporation
-
Recent Revenue History
-
Acquisitions and Collaborations
-
Mass Spectrometry
-
Microbiology
-
Molecular PCR
-
COVID-19
-
Danaher Corporation
-
Dexcom
-
DiaSorin
-
Recent Revenue History
-
Immunoassays
-
Molecular
-
COVID-19
-
Exact Sciences
-
Recent Revenue History
-
COVID-19
-
Hologic, Inc.
-
Recent Revenue History
-
PANTHER Molecular System
-
HIV Testing
-
Sexually Transmitted Infections
-
Infectious Diseases
-
Cytology
-
COVID-19
-
Illumina
-
Recent Revenue History
-
COVID-19
-
Instrument Laboratory/ Werfen
-
Expansion
-
Coagulation
-
Acute Care
-
Natera
-
Recent Revenue History
-
Prenatal Paternity Testing
-
QuidelOrtho Corporation
-
Recent Revenue History
-
Immunoassays
-
Rapid Immunoassays
-
The Solana Business
-
Molecular – Savanna
-
Blood Bank
-
COVID-19
-
Revvity
-
Roche Diagnostics
-
Recent Revenue History
-
Hematology
-
Core Lab
-
Immunoassays
-
HIV
-
Core Molecular
-
Digital PCR
-
Diabetes Care
-
Coagulation
-
cobas Liat System – POC
-
HPV
-
Blood Bank
-
Transplant Medicine
-
Cancer Companion Testing
-
COVID-19
-
Siemens Healthineers (Siemens)
-
Recent Revenue History
-
Immunoassays
-
Hematology
-
Molecular
-
Acute Care – POC
-
COVID-19
-
Sysmex Corporation
-
Recent Revenue History
-
Hematology
-
Coagulation
-
Urinalysis
-
Immunoassays
-
Precision Medicine / Companion Test Diagnostics
-
Oncology
-
COVID-19
-
Thermo Fisher Scientific Inc.
-
Recent Revenue History
-
Immunoassays
-
Microbiology
-
Next Generation Sequencing
-
Molecular and qPCR
-
Mass Spectrometry
-
COVID-19
-
Werfen
-
Recent Revenue History
-
Hematology and Coagulation
-
Autoimmunity
|
IVD Test Procedure Volumes, 2024-2029
8 Oct 2024
Kalorama Information's IVD Test Procedure Volumes, 2024-2029 report provides a deep dive into the global trends shaping in vitro diagnostic (IVD) procedural volumes. Designed to complement Kalorama’s comprehensive market analysis in The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition, this essential report delivers actionable data on the growth, challenges, and emerging opportunities in the IVD space.
As a rapidly evolving market, the IVD landscape in 2024 is set to thrive, driven by new technologies, evolving healthcare spending, and a surge in demand for precision diagnostics. Our report not only identifies the most significant procedural segments but also breaks down the impact of ongoing innovations.
With this detailed market research, you can stay ahead of industry developments and make informed business decisions. Whether you are looking to expand your product portfolio, explore new market segments, or refine your strategic approach, IVD Test Procedure Volumes, 2024-2029 offers the data and insights you need to succeed.
Why Choose This Report?
- Comprehensive Market Data
Gain an in-depth understanding of IVD procedural volumes by type, region, and country. From self-testing and professional point-of-care (POC) to clinical chemistry, hematology, and beyond—this report covers it all.
- Unmatched Insights into Growth Opportunities
Identify high-growth segments by exploring emerging markets and the potential of precision medicine applications.
- Forward-Looking Analysis
Understand the trends impacting the IVD market, including shifts in regulatory landscapes, new product developments, and changing disease profiles. This report provides a comprehensive forecast from 2024 to 2029.
- Strategic Guidance for Industry Players
Discover how market dynamics, healthcare system trends, and cost pressures are shaping the future of IVD. Use these insights to develop strategies for product positioning, market entry, and growth.
Scope & Methodology
The report includes:
- Global IVD Procedure Volumes by type, covering self and professional POC, clinical chemistry, immunoassay, molecular diagnostics, hematology, coagulation, microbiology, blood banking, and histology/cytology.
- Regional and Country-Specific Data for IVD procedures and their projected growth rates.
- Cost Analysis of various IVD tests to evaluate profitability and potential revenue streams.
Page Count: 405
|
More information about this product
Other Users Also Viewed
29 Aug 2024
Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-…
30-Country IVD Market Atlas, 2024 (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries) [September 2024 update]
26 Sep 2024
|
